We’ve made embryo screening completely safe and noninvasvie. The safety of this approach has been demonstrated in preclinical studies using mouse models. By eliminating invasive procedures and reducing operator-dependent variability, our method offers a consistently safe and standardised approach to assessing embryo quality.
Revolutionising Embryo Screening for fertility providers
Next-generation, noninvasvie screening solution designed to boost success rates and streamline decision-making.
Contact us
Evidence-based Metabolomic Embryo Screening
You Can Rely On
Safe and Standardized
Metabolomic Screening
AI-Powered Embryo
Viability Prediction
By training advanced AI models on metabolic profiles, our technology accurately predicts oocyte and embryo maturation and developmental potential, enabling more informed and objective embryo selection.
Rapid Results and
Seamless Workflow
Integration
Specifically designed for IVF clinics, our system integrates effortlessly into existing laboratory workflows. Results are available within an hour, empowering data-driven decision-making without disrupting standard lab operations.
Dive into our discoveries
Oocyte Quality Assessment
microMRS-MED enables high-resolution detection of metabolic biomarkers with unmatched precision, reliably discriminating mature (MII) from immature (GV/MI) oocytes (p ≤ 0.05).
*These findings are derived from analyses of donated and clinically discarded immature and in vitro-matured human oocytes, collected under appropriate ethical approvals and following the provision of informed consent by patients.
Blastulation Prediction
microMRS-MED predicts early embryo viability with >90% accuracy and >85% sensitivity and forecasts subsequent embryonic development with >80% accuracy and >70% sensitivity.
*These results are based on data collected from in vitro–produced bovine embryos.
Morphokinetics Trajectories Prediction
microMRS-MED predicts blastocyst expansion and hatching with > 70% accuracy and > 65% sensitivity, linking key morphokinetics events with embryo metabolic profile.
*These results are based on data collected from in vitro–produced bovine embryos.
